PDCD1 and neoplasm: Remarkably, in vitro results showed that the secreted anti-PD-L1 IgG1 or IgG4 can interact with the PD-L1+ RCC cells, reverse upregulation of the exhaustion markers PD-1, TIM-3 and LAG-3 and restore tumor cell killing.